文献速递心境障碍

氯胺酮调节抑郁患者与健康人的额-纹状体环路

Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals.
PubMed 文献 · Mol Psychiatry · 2020-09-14

该双盲安慰剂对照交叉试验纳入33例难治性重性抑郁障碍(TRD)患者和25名健康志愿者(HV),于氯胺酮或安慰剂输注后2天采集静息态fMRI。氯胺酮使TRD患者额-纹状体功能连接增强至接近HV水平,却使HV连接模式向TRD安慰剂状态偏移,且初步显示这些效应大多不伴炎症(C反应蛋白)变化,并与TRD组急性和持续症状改善相关。

要点

  • 氯胺酮使TRD患者额-纹状体功能连接向健康人水平正常化。
  • 氯胺酮使健康志愿者额-纹状体连接向TRD安慰剂状态偏移。
  • 上述效应初步显示大多不伴炎症变化,并与TRD症状改善相关。

核心结论

  • 氯胺酮在TRD患者中使额-纹状体连接正常化,在健康志愿者中则破坏该连接,且独立于炎症过程。

研究设计与样本

  • 双盲、安慰剂对照、交叉试验,纳入33例难治性重性抑郁障碍(TRD)患者和25名健康志愿者(HV)。
  • 于氯胺酮和安慰剂输注后2天采集静息态功能磁共振成像(rsfMRI),以纹状体种子为基础探测额-纹状体环路功能连接。
  • 最终样本:氯胺酮后TRD n=27、HV n=19;安慰剂后TRD n=25、HV n=18。

主要发现

  • 氯胺酮使TRD参与者的额-纹状体功能连接增强,趋向健康志愿者观察到的水平。
  • 氯胺酮使健康志愿者的连接模式向TRD参与者安慰剂状态偏移。
  • 初步发现这些效应大多在无炎症(C反应蛋白)变化的情况下观察到。
  • 这些效应与TRD组急性和持续的症状改善相关。

临床怎么用

  • 提示额-纹状体奖赏环路可能是氯胺酮作用机制的重要环节,尤其与动机症状变化相关。
  • 氯胺酮对额-纹状体连接的影响在健康与疾病状态下方向不同,临床解读需结合个体状态。

局限性

  • 炎症相关结果为初步发现,原文未报告具体炎症指标数值或统计阈值。
  • 影像最终样本量小于初始纳入样本量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ketamine improves motivation-related symptoms in depression but simultaneously elicits similar symptoms in healthy individuals, suggesting that it might have different effects in health and disease. This study examined whether ketamine affects the brain's fronto-striatal system, which is known to drive motivational behavior. The study also assessed whether inflammatory mechanisms-which are known to influence neural and behavioral motivational processes-might underlie some of these changes. These questions were explored in the context of a double-blind, placebo-controlled, crossover trial of ketamine in 33 individuals with treatment-resistant major depressive disorder (TRD) and 25 healthy volunteers (HVs). Resting-state functional magnetic resonance imaging (rsfMRI) was acquired 2 days post-ketamine (final sample: TRD n = 27, HV n = 19) and post-placebo (final sample: TRD n = 25, HV n = 18) infusions and was used to probe fronto-striatal circuitry with striatal seed-based functional connectivity. Ketamine increased fronto-striatal functional connectivity in TRD participants toward levels observed in HVs while shifting the connectivity profile in HVs toward a state similar to TRD participants under placebo. Preliminary findings suggest that these effects were largely observed in the absence of inflammatory (C-reactive protein) changes and were associated with both acute and sustained improvements in symptoms in the TRD group. Ketamine thus normalized fronto-striatal connectivity in TRD participants but disrupted it in HVs independently of inflammatory processes. These findings highlight the potential importance of reward circuitry in ketamine's mechanism of action, which may be particularly relevant for understanding ketamine-induced shifts in motivational symptoms.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Mkrtchian A, Evans JW, Kraus C, et al. Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals. Mol Psychiatry. 2020. PMID: 32929215. doi:10.1038/s41380-020-00878-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。